
About Fugenbio
Fugenbio is a Healthcare company based in Seoul (South Korea) founded in 2005. Provider of artificial cultural method of Ceriporia lacerata for active ingredient of CLEPS. Fugenbio offers products and services including CLEPS® Essence and Cellona. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity in India is (주)퓨젠바이오 (U99999MH1977PLC010754).
Company details
FUGENBIO provider an artificial cultural method of Ceriporia lacerata for the active ingredient of CLEPS. The Ceriporia lacerata is a white-rot fungus which has applications in food and medicine manufacturing. The company uses proprietary technology for the production of active ingredients such as extracellular polysaccharide (EPS); CLEPS for functional ingredients that can be used in the development of medicine and food additives like control of blood sugar and blood pressure, and improvement of liver and immune function, etc.
- Headquarters Seoul, South Korea
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website fugenbio.com
- Legal Name (주)퓨젠바이오
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
Associated legal entities of Fugenbio
Fugenbio operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | View details |
Products & Services of Fugenbio
Fugenbio offers a comprehensive portfolio of products and services, including CLEPS® Essence and Cellona.
Essence for deep skin penetration and cellular health improvement.
Supplement for blood sugar control and insulin resistance management.
Web traffic of Fugenbio
The website of Fugenbio (fugenbio.com) receives about 3.9K visits a month.
- Monthly visits3.9K
▼ 32.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fugenbio
Complete news archive for Fugenbio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fugenbio
Fugenbio was founded in 2005.
Fugenbio is headquartered in Seoul, South Korea.
FUGENBIO provider an artificial cultural method of Ceriporia lacerata for the active ingredient of CLEPS. The Ceriporia lacerata is a white-rot fungus which has applications in food and medicine manufacturing. The company uses proprietary technology for the production of active ingredients such as extracellular polysaccharide (EPS); CLEPS for functional ingredients that can be used in the development of medicine and food additives like control of blood sugar and blood pressure, and improvement of liver and immune function, etc.
Fugenbio offers CLEPS® Essence and Cellona.
Fugenbio operates through ,.
